SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ATHE

Alterity Therapeutics Ltd (NASDAQ:ATHE)

AU · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.19+0.10 (+4.78%)
 
Market cap
$37.1M
Insider Score
Analyst consensus
Listed since
Sep 29, 2003
Insider Score
/ 100
ATHE Insider Score

ALTERITY THERAPEUTICS LTD has a live Insider Score.

Scored on 1 qualifying trade from 1 insider in the last 90 days.

Unlock the score

ATHE Income Statement

Fiscal PeriodQ2 2026Q4 2025Q2 2025Q4 2024Q2 2024Q4 2023
Period EndingJun 30, 2026Dec 31, 2025Jun 30, 2025Dec 31, 2024Jun 30, 2024Dec 31, 2023
Revenue0.000.003.83 M1.61 M2.12 M1.90 M
Revenue Growth (YoY)-100.00 %-100.00 %150.44 %-32.69 %-23.36 %-19.43 %
Cost of Revenue58.46 K56.83 K63.92 K63.60 K73.61 K73.92 K
Gross Profit-58.46 K-56.83 K3.77 M1.54 M2.04 M1.83 M
SG&A Expense5.60 M5.06 M2.17 M3.31 M2.68 M2.08 M
R&D Expense9.93 M7.70 M8.69 M5.72 M12.28 M6.36 M
Operating Expenses15.52 M12.76 M10.86 M9.03 M14.98 M8.45 M
Operating Income-15.58 M-12.82 M-7.09 M-7.49 M-12.98 M-4.50 M
Pretax Income-14.74 M-12.13 M-4.91 M-8.78 M-14.69 M-4.39 M
Tax Provision-765.31 K-2.69 M68.06 K-1.61 M-2.07 M-1.90 M
Net Income-13.98 M-9.44 M-4.97 M-7.17 M-12.62 M-6.51 M
EPS (Basic)-0.78-0.54-0.42-0.84-1.20-1.56
EPS (Diluted)-0.78-0.54-0.42-0.84-1.20-1.56
Shares Outstanding18.13 M16.97 M12.47 M8.54 M10.51 M4.17 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.